HCl-induced inflammatory mediators in cat esophageal mucosa and inflammatory mediators in esophageal circular muscle in an in vitro model of esophagitis

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 290, Issue 6, 2006, Pages

  Cheng, Ling ^a   Cao, Weibiao ^a   Fiocchi, Claudio ^b   Behar, Jose ^a   Biancani, Piero ^a   Harnett, Karen M ^a,c  

^a BROWN UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

Author keywords

Cytokines; Inflammation; Reactive oxygen species; Smooth muscle contraction

Indexed keywords

[2 METHOXY 3 (N OCTADECYLCARBAMOYLOXY)PROPYL] (2 THIAZOLIOETHYL) PHOSPHATE; AUTACOID; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CITRIC ACID CYCLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG MECHANISM; ELECTROSTIMULATION; ESOPHAGITIS; ESOPHAGUS MUCOSA; ESOPHAGUS MUSCLE; IN VITRO STUDY; INFLAMMATION; MALE; MOTOR PERFORMANCE; MUSCLE CONTRACTION; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; SMOOTH MUSCLE CONTRACTION; SUPERNATANT;

ANIMALS; CATS; DISEASE MODELS, ANIMAL; ESOPHAGITIS; ESOPHAGUS; INFLAMMATION MEDIATORS; MALE; MUCOUS MEMBRANE; MUSCLE, SMOOTH; PHENYLPROPIONATES; REACTIVE OXYGEN SPECIES;

EID: 33646868166     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00576.2005     Document Type: Article

References (55)

1. Bae YS, Kim Y, Kim JH, Lee TG, Suh PG, and Ryu SH. Independent functioning of cytosolic phospholipase A2 and phospholipase D1 in Trp-Lys-Tyr-Met-Val-D-Met-induced superoxide generation in human monocytes. J Immunol 164: 4089-4096, 2000.
2. Banfi B, Maturana A, Jaconi S, Arnaudeau S, Laforge T, Sinha B, Ligeti E, Demaurex N, and Krause KH. A mammalian H+ channel generated through alternative splicing of the NADPH oxidase homolog NOH-1. Science 287: 138-142, 2000.
3. Barbieri SS, Cavalca V, Eligini S, Brambilla M, Caiani A, Tremoli E, and Colli S. Apocynin prevents cyclooxygenase 2 expression in human monocytes through NADPH oxidase and glutathione redox-dependent mechanisms. Free Radic Biol Med 37: 156-165, 2004.
4. Biancani P, Billett G, Hillemeier C, Nissenshon M, Rhim BY, Sweczack S, and Behar J. Acute experimental esophagitis impairs signal transduction in cat LES circular muscle. Gastroenterology 103: 1199-1206, 1992.
5. Bligh EG and Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917, 1959.
6. Boulanger MJ, Chow DC, Brevnova EE, and Garcia KC. Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex. Science 300: 2101-2104, 2003.
7. Bouzidi F and Doussiere J. Binding of arachidonic acid to myeloid-related proteins (S100A8/A9) enhances phagocytic NADPH oxidase activation. Biochem Biophys Res Commun 325: 1060-1065, 2004.
8. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Annal Biochem 72: 248-254, 1976.
9. Brigelius-Flohe R, Banning A, Kny M, and Bol GF. Redox events in interleukin-1 signaling. Arch Biochem Biophys 423: 66-73, 2004.
10. Bussolino F, Breviario F, Aglietta M, Sanavio F, Bosia A, and Dejana E. Studies on the mechanism of interleukin 1 stimulation of platelet activating factor synthesis in human endothelial cells in culture. Biochim Biophys Acta 927: 43-54, 1987.
11. Cao W, Cheng L, Behar J, Fiocchi C, Biancani P, and Harnett KM. Proinflammatory cytokines alter/reduce esophageal circular muscle contraction in experimental cat esophagitis. Am J Physiol Gastrointest Liver Physiol 287: G1131-G1139, 2004.
12. Cao WB, Harnett KM, Chen Q, Jain MK, Behar J, and Biancani P. Group I secreted PLA2 (sPLA2) and arachidonic acid metabolites in the maintenance of cat LES tone. Am J Physiol Gastrointest Liver Physiol 277: G585-G598, 1999.
13. Chen WP, Chen A, and Lin CY. In vitro effects of interleukins on human mesangial cells: implications for glomerulonephritis. J Pathol 175: 327-337, 1995.
14. Cheng L, Cao W, Behar J, Biancani P, and Harnett KM. Inflammation induced changes in arachidonic acid metabolism in cat LES circular muscle. Am J Physiol Gastrointest Liver Physiol 288: G787-G797, 2005.
15. Cheng L, Cao W, Fiocchi C, Behar J, Biancani P, and Harnett KM. In vitro model of acute esophagitis in the cat. Am J Physiol Gastrointest Liver Physiol 289: G860-G869, 2005.
16. Cheng L, Cao W, Fiocchi C, Behar J, Biancani P, and Harnett KM. Platelet-activating factor and prostaglandin E2 impair esophageal ACh release in experimental esophagitis. Am J Physiol Gastrointest Liver Physiol 289: G418-G428, 2005.
17. Cheng L, Harnett KM, Cao W, Liu F, Behar J, Fiocchi C, and Biancani P. Hydrogen peroxide reduces lower esophageal sphincter tone in human esophagitis. Gastroenterology 129: 1675-1685, 2005.
18. Dupre DJ, Le Gouill C, Rola-Pleszczynski M, and Stankova J. Inverse agonist activity of selected ligands of platelet-activating factor receptor. J Pharmacol Exp Ther 299: 358-365, 2001.
19. Foubert TR, Burritt JB, Taylor RM, and Jesaitis AJ. Structural changes are induced in human neutrophil cytochrome b by NADPH oxidase activators, LDS, SDS, and arachidonate: intermolecular resonance energy transfer between trisulfopyrenyl-wheat germ agglutinin and cytochrome b(558). Biochim Biophys Acta 1567: 221-231, 2002.
20. Gaumond F, Fortin D, Stankova J, and Rola-Pleszczynski M. Differential signaling pathways in platelet-activating factor-induced proliferation and interleukin-6 production by rat vascular smooth muscle cells. J Cardiovasc Pharmacol 30: 169-175, 1997.
21. Haddad JJ. Redox regulation of pro-inflammatory cytokines and IκB-α/NFαB nuclear translocation and activation. Biochem Biophys Res Commun 296: 847-856, 2002.
22. Hart BA and Simons JM. Metabolic activation of phenols by stimulated neutrophils: a concept for a selective type of anti-inflammatory drug. Biotechnol Ther 3: 119-135, 1992.
23. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, and Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374: 1-20, 2003.
24. Honda Z, Ishii S, and Shimizu T. Platelet-activating factor receptor. J Biochem (Tokyo) 131: 773-779, 2002.
25. Honda Z, Takano T, Gotoh Y, Nishida E, Ito K, and Shimizu T. Transfected platelet-activating factor receptor activates mitogen-activated protein (MAP) kinase and MAP kinase kinase in Chinese hamster ovary cells. J Biol Chem 269: 2307-2315, 1994.
26. Hwang YS, Jeong M, Park JS, Kim MH, Lee DB, Shin BA, Mukaida N, Ellis LM, Kim HR, Ahn BW, and Jung YD. Interleukin-1β stimulates IL-8 expression through MAP kinase and ROS signaling in human gastric carcinoma cells. Oncogene 23: 6603-6611, 2004.
27. Ishii S and Shimizu T. Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog Lipid Res 39: 41-82, 2000.
28. Kerkhoff C, Nacken W, Benedyk M, Dagher MC, Sopalla C, and Doussiere J. The arachidonic acid-binding protein S100A8/A9 promotes NADPH oxidase activation by interaction with p67phox and Rac-2. Faseb J, 2005.
29. Kosmidou I, Vassilakopoulos T, Xagorari A, Zakynthinos S, Papapetropoulos A, and Roussos C. Production of interleukin-6 by skeletal myotubes: role of reactive oxygen species. Am J Respir Cell Mol Biol 26: 587-593, 2002.
30. Kuruvilla A, Putcha G, Poulos E, and Shearer WT. Tyrosine phosphorylation of phospholipase C concomitant with its activation by platelet-activating factor in a human B cell line. J Immunol 151: 637-648, 1993.
31. Lacasse C, Turcotte S, Gingras D, Stankova J, and Rola-Pleszczynski M. Platelet-activating factor stimulates interleukin-6 production by human endothelial cells and synergizes with tumor necrosis factor for enhanced production of granulocyte-macrophage colony stimulating factor. Inflammation 21: 145-158, 1997.
32. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4: 181-189, 2004.
33. Lindstrom TM and Bennett PR. 15-Deoxy-Δ12,14-prostaglandin j2 inhibits interleukin-1β-induced nuclear factor-κb in human amnion and myometrial cells: mechanisms and implications. J Clin Endocrinol Metab 90: 3534-3543, 2005.
34. Liu B, Nakashima S, Kanoh H, Takano T, Shimizu T, and Nozawa Y. Activation of phospholipase D in Chinese hamster ovary cells expressing platelet-activating factor receptor. J Biochem (Tokyo) 116: 882-891, 1994.
35. Lo YY, Conquer JA, Grinstein S, and Cruz TF. Interleukin-1β induction of c-fos and collagenase expression in articular chondrocytes: involvement of reactive oxygen species. J Cell Biochem 69: 19-29, 1998.
36. Lukashova V, Asselin C, Krolewski JJ, Rola-Pleszczynski M, and Stankova J. G-protein-independent activation of Tyk2 by the platelet-activating factor receptor. J Biol Chem 276: 24113-24121, 2001.
37. Mendes AF, Caramona MM, Carvalho AP, and Lopes MC. Hydrogen peroxide mediates interleukin-1β-induced AP-1 activation in articular chondrocytes: implications for the regulation of iNOS expression. Cell Biol Toxicol 19: 203-214, 2003.
38. Nasu K, Narahara H, Matsui N, Kawano Y, Tanaka Y, and Miyakawa I. Platelet-activating factor stimulates cytokine production by human endometrial stromal cells. Mol Hum Reprod 5: 548-553, 1999.
39. Nauseef WM. The NADPH-dependent oxidase of phagocytes. Proc Assoc Am Physicians 111: 373-382, 1999.
40. Ndengele MM, Muscoli C, Wang ZQ, Doyle TM, Matuschak GM, and Salvemini D. Superoxide potentiates NFκB activation and modulates endotoxin-induced cytokine production in alveolar macrophages. Shock 23: 186-193, 2005.
41. Pei Y, Barber LA, Murphy RC, Johnson CA, Kelley SW, Dy LC, Fertel RH, Nguyen TM, Williams DA, and Travers JB. Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis. J Immunol 161: 1954-1961, 1998.
42. Prescott SM, Zimmerman GA, and McIntyre TM. Platelet-activating factor. J Biol Chem 265: 17381-17384, 1990.
43. Roth M, Nauck M, Yousefi S, Tamm M, Blaser K, Perruchoud AP, and Simon HU. Platelet-activating factor exerts mitogenic activity and stimulates expression of interleukin 6 and interleukin 8 in human lung fibroblasts via binding to its functional receptor. J Exp Med 184: 191-201, 1996.
44. Roy D, Sarkar S, and Felty Q. Levels of IL-1β control stimulatory/inhibitory growth of cancer cells. Front Biosci 11: 889-898, 2006.
45. Sano M, Fukuda K, Sato T, Kawaguchi H, Suematsu M, Matsuda S, Koyasu S, Matsui H, Yamauchi-Takihara K, Harada M, Saito Y, and Ogawa S. ERK and p38 MAPK, but not NFκB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts. Circ Res 89: 661-669, 2001.
46. Shi C, Zhao X, Wang X, and Andersson R. Role of nuclear factor-κB, reactive oxygen species and cellular signaling in the early phase of acute pancreatitis. Scand J Gastroenterol 40: 103-108, 2005.
47. Stafforini DM, McIntyre TM, Zimmerman GA, and Prescott SM. Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. Crit Rev Clin Lab Sci 40: 643-672, 2003.
48. Stolk J, Hiltermann TJ, Dijkman JH, and Verhoeven AJ. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am J Respir Cell Mol Biol 11: 95-102, 1994.
49. Sugano T, Narahara H, Nasu K, Arima K, Fujisawa K, and Miyakawa I. Effects of platelet-activating factor on cytokine production by human uterine cervical fibroblasts. Mol Hum Reprod 7: 475-481, 2001.
50. Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK, and Lambeth JD. Cell transformation by the superoxide-generating oxidase Mox1. Nature 401: 79-82, 1999.
51. Sung JY, Hong JH, Kang HS, Choi I, Lim SD, Lee JK, Seok JH, Lee JH, and Hur GM. Methotrexate suppresses the interleukin-6 induced generation of reactive oxygen species in the synoviocytes of rheumatoid arthritis. Immunopharmacology 47: 35-44, 2000.
52. Takada Y, Mukhopadhyay A, Kundu GC, Mahabeleshwar GH, Singh S, and Aggarwal BB. Hydrogen peroxide activates NFκB through tyrosine phosphorylation of IκBα and serine phosphorylation of p65: evidence for the involvement of IκBα kinase and Syk protein-tyrosine kinase. J Biol Chem 278: 24233-24241, 2003.
53. Tamm M, Bihl M, Eickelberg O, Stulz P, Perruchoud AP, and Roth M. Hypoxia-induced interleukin-6 and interleukin-8 production is mediated by platelet-activating factor and platelet-derived growth factor in primary human lung cells. Am J Respir Cell Mol Biol 19: 653- 661, 1998.
54. Wassmann S, Stumpf M, Strehlow K, Schmid A, Schieffer B, Bohm M, and Nickenig G. Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circ Res 94: 534-541, 2004.
55. Yu JH, Lim JW, Kim H, and Kim KH. NADPH oxidase mediates interleukin-6 expression in cerulein-stimulated pancreatic acinar cells. Int J Biochem Cell Biol 37: 1458-1469, 2005.